News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
484,832 Results
Type
Article (8026)
Company Profile (140)
Press Release (476665)
Multimedia
Podcasts (4)
Webinars (6)
Section
Business (166761)
Career Advice (304)
Deals (25743)
Drug Delivery (7)
Drug Development (52895)
Employer Resources (14)
FDA (9763)
Job Trends (8573)
News (238240)
Policy (17903)
Tag
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (3)
2027 Biotech Bay Standard (4)
2027 Genetown Elite (1)
2027 Genetown Standard (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (1)
Academia (487)
Accelerated approval (24)
ADA (19)
Adcomms (1)
Allergies (96)
Alliances (33158)
ALS (105)
Alzheimer's disease (976)
Antibody-drug conjugate (ADC) (267)
Approvals (10382)
Artificial intelligence (322)
ASCO (160)
Autoimmune disease (205)
Automation (28)
Bankruptcy (262)
Best Places to Work (6959)
BIO (36)
Biologics (2)
BIOSECURE Act (1)
Biosimilars (109)
BioSpace Insights (17)
Biotechnology (88)
Bladder cancer (138)
Brain cancer (29)
Breast cancer (510)
Cancer (3656)
Cardiovascular disease (222)
Career advice (245)
Career pathing (1)
CAR-T (174)
Celiac Disease (1)
Cell therapy (478)
Cervical cancer (34)
Clinical research (47896)
Collaboration (1245)
Commercialization (3)
Compensation (1470)
Complete response letters (34)
COVID-19 (754)
CRISPR (63)
C-suite (753)
Cystic fibrosis (85)
Data (5667)
Denatured (4)
Depression (102)
Dermatology (62)
Diabetes (344)
Diagnostics (4189)
Digital health (39)
Diversity (1)
Diversity, equity & inclusion (4)
Drug discovery (155)
Drug pricing (7)
Drug shortages (2)
Duchenne muscular dystrophy (164)
Earnings (73721)
Editorial (1)
Employer branding (2)
Employer resources (14)
Events (87641)
Executive appointments (701)
FDA (12404)
Fibrodysplasia Ossificans Progressiva (9)
Friedreich's ataxia (18)
Frontotemporal dementia (23)
Funding (919)
Gene editing (125)
Generative AI (9)
Gene therapy (318)
GLP-1 (290)
Government (943)
Grass and pollen (2)
Guidances (281)
Healthcare (9319)
Hematology (94)
HIV (52)
Huntington's disease (22)
IgA nephropathy (64)
Immunology and inflammation (99)
Immuno-oncology (56)
Indications (158)
Infectious disease (942)
Inflammatory bowel disease (126)
Inflation Reduction Act (4)
Influenza (84)
Intellectual property (255)
Interviews (41)
IPO (12387)
IRA (2)
Job creations (1968)
Job search strategy (235)
JPM (1)
Kidney cancer (16)
Layoffs (59)
Legal (5195)
Licensing (8)
Liver cancer (44)
Longevity (17)
Lung cancer (509)
Lymphoma (251)
Machine learning (27)
Management (3)
Manufacturing (535)
Marketing (8)
MASH (118)
Medical device (8661)
Medtech (8806)
Mergers & acquisitions (14389)
Metabolic disorders (711)
mRNA (55)
Multiple sclerosis (102)
NASH (4)
Neurodegenerative disease (220)
Neuropsychiatric disorders (39)
Neuroscience (1826)
NextGen: Class of 2026 (3150)
Non-profit (841)
Obesity (226)
Opinion (10)
Ovarian cancer (159)
Pain (172)
Pancreatic cancer (197)
Parkinson's disease (201)
Partnered (12)
Patents (476)
Patient recruitment (509)
Peanut (31)
People (41253)
Pharmaceutical (30)
Pharmacy benefit managers (8)
Phase 1 (15474)
Phase 2 (21388)
Phase 3 (14411)
Pipeline (7354)
Policy (18)
Postmarket research (1570)
Preclinical (6541)
Press Release (34)
Prostate cancer (190)
Psychedelics (7)
Radiopharmaceuticals (189)
Rare diseases (575)
Real estate (3019)
Recruiting (6)
Regulatory (14836)
Reports (21)
Research institute (581)
Resumes & cover letters (45)
Rett syndrome (42)
RNA editing (5)
RSV (48)
Schizophrenia (100)
Series A (156)
Series B (121)
Service/supplier (5)
Sickle cell disease (63)
Spinal muscular atrophy (88)
Sponsored (5)
Startups (2021)
Stomach cancer (3)
Supply chain (51)
Vaccines (323)
Venture capital (17)
Weight loss (74)
Women's health (79)
Date
Today (47)
Last 7 days (214)
Last 30 days (1587)
Last 365 days (19061)
2026 (12359)
2025 (19257)
2024 (23000)
2023 (26540)
2022 (34597)
2021 (37169)
2020 (33475)
2019 (23286)
2018 (17472)
2017 (18771)
2016 (17934)
2015 (24284)
2014 (21687)
2013 (18138)
2012 (20224)
2011 (20444)
2010 (20332)
Location
Africa (228)
Alabama (73)
Alaska (2)
Arizona (305)
Arkansas (11)
Asia (17901)
Australia (2098)
California (11992)
Canada (3149)
China (524)
Colorado (485)
Connecticut (409)
Delaware (208)
Europe (24691)
Florida (1789)
Georgia (380)
Hawaii (3)
Idaho (46)
Illinois (700)
India (51)
Indiana (314)
Iowa (15)
Japan (403)
Kansas (101)
Kentucky (30)
Louisiana (27)
Maine (26)
Maryland (1202)
Massachusetts (7862)
Michigan (308)
Minnesota (560)
Mississippi (4)
Missouri (82)
Montana (20)
Nebraska (11)
Nevada (116)
New Hampshire (60)
New Jersey (2621)
New Mexico (12)
New York (2822)
North Carolina (1280)
North Dakota (4)
Northern California (6006)
Ohio (278)
Oklahoma (14)
Oregon (16)
Pennsylvania (2268)
Puerto Rico (20)
Rhode Island (30)
South America (406)
South Carolina (77)
South Dakota (1)
Southern California (4984)
Tennessee (120)
Texas (1942)
United States (38922)
Utah (360)
Vermont (1)
Virginia (153)
Washington D.C. (38)
Washington State (929)
West Virginia (1)
Wisconsin (73)
Wyoming (1)
484,832 Results for "zeus inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Novo Nordisk provides update on the ZEUS phase 3 trial in people with ASCVD, CKD and inflammation
July 31, 2026
·
3 min read
Press Releases
Zeus Launches PFX™ Platform and Introduces PFX Flex™ Sub-Lite-Wall™, Advancing the Future of Catheter Innovation
January 30, 2026
·
3 min read
Business
Zeus Names Chief Technology Officer
Zeus, a world leader in polymer extrusion and catheter manufacturing, announces the appointment of Suresh Sainath as Chief Technology Officer.
April 22, 2024
·
2 min read
FDA
ZEUS Scientific Announces FDA Clearance for the ZEUS dIFine® IFA Imaging and Pattern Recognition System
The U.S. Food and Drug Administration (FDA) has cleared ZEUS Scientific’s dIFine® digital immunofluorescence system* for use with ZEUS’ ANA HEp-2 indirect fluorescent antibody (IFA) assay.
May 3, 2022
·
2 min read
Immunology and inflammation
Novo’s late-stage IL-6 stumble shakes inflammation space
Novo Nordisk was banking on the inflammatory benefits of its investigational therapy ziltivekimab to improve cardiovascular outcomes. Last week’s Phase 3 failure dashed not just the Danish pharma’s hopes but that of other drugmakers working on the same pathway.
August 3, 2026
·
2 min read
·
Tristan Manalac
BioMidwest
Zeus Launches PTFE Sub-Lite-Wall® Multi-Lumen Tubing for Steerable Catheters
Zeus, the global leader in advanced polymer solutions, announced that it has added PTFE Sub-Lite-Wall® multi-lumen tubing to its product portfolio.
February 2, 2022
·
3 min read
BioMidwest
Zeus Industrial Products to Integrate Catheter-Based Contract Manufacturer CathX Medical
Zeus Industrial Products, Inc., the global leader in advanced polymer solutions, announced that it has finalized an agreement to integrate CathX Medical Inc. into its organization.
June 9, 2021
·
5 min read
Cardiovascular disease
Novo’s IL-6 inhibitor fails in cardiovascular Phase 3, plunging shares more than 9%
Novo Nordisk’s IL-6 inhibitor ziltivekimab failed to reduce the risk of cardiovascular events in the late-stage trial, dashing hopes for an edge in the hyper-competitive cardiometabolic space.
July 31, 2026
·
2 min read
·
Michael Gibney
Press Releases
Tevogen Bio Holdings Inc. Becomes Tevogen Inc.
July 29, 2026
·
4 min read
Deals
Precisio Biotix Therapeutics Acquires London-Headquartered CC Bio, Adding World-class Antibacterial Platform and Top Scientists
Precisio Biotix Therapeutics announced the acquisition of CC Bio, creator of the ZEUS anti-bacterial lysin platform.
March 1, 2024
·
4 min read
1 of 48,484
Next
